WO2004048586A1 - 光学活性な1−シクロヘキシル−2−プロピン−1−オールの製造方法 - Google Patents
光学活性な1−シクロヘキシル−2−プロピン−1−オールの製造方法 Download PDFInfo
- Publication number
- WO2004048586A1 WO2004048586A1 PCT/JP2003/015071 JP0315071W WO2004048586A1 WO 2004048586 A1 WO2004048586 A1 WO 2004048586A1 JP 0315071 W JP0315071 W JP 0315071W WO 2004048586 A1 WO2004048586 A1 WO 2004048586A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microorganism
- cyclohexyl
- reducing
- group
- propyn
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 23
- CMJHRFATHWISFN-UHFFFAOYSA-N 1-cyclohexylprop-2-yn-1-ol Chemical compound C#CC(O)C1CCCCC1 CMJHRFATHWISFN-UHFFFAOYSA-N 0.000 title abstract description 16
- 244000005700 microbiome Species 0.000 claims abstract description 41
- 125000000468 ketone group Chemical group 0.000 claims abstract description 25
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 24
- 230000001603 reducing effect Effects 0.000 claims description 21
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 230000000694 effects Effects 0.000 claims description 13
- -1 1-cyclohexyl Chemical group 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 150000003180 prostaglandins Chemical class 0.000 claims description 9
- 235000017388 Geotrichum candidum Nutrition 0.000 claims description 6
- 241000159512 Geotrichum Species 0.000 claims description 5
- 241000159578 Dipodascus armillariae Species 0.000 claims description 4
- 241000178951 Endomyces Species 0.000 claims description 3
- 241000233866 Fungi Species 0.000 claims description 3
- 238000006722 reduction reaction Methods 0.000 claims description 3
- 241000453701 Galactomyces candidum Species 0.000 claims 2
- 241000159517 Galactomyces reessii Species 0.000 claims 1
- OSSQSXOTMIGBCF-UHFFFAOYSA-N non-1-yne Chemical compound CCCCCCCC#C OSSQSXOTMIGBCF-UHFFFAOYSA-N 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- VRZSUVFVIIVLPV-UHFFFAOYSA-N 1-cyclohexylprop-2-yn-1-one Chemical compound C#CC(=O)C1CCCCC1 VRZSUVFVIIVLPV-UHFFFAOYSA-N 0.000 abstract description 2
- 238000006243 chemical reaction Methods 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 15
- 230000003287 optical effect Effects 0.000 description 9
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 238000003786 synthesis reaction Methods 0.000 description 7
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 238000005273 aeration Methods 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 244000168141 Geotrichum candidum Species 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 229920000858 Cyclodextrin Polymers 0.000 description 3
- 238000005481 NMR spectroscopy Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 101150041968 CDC13 gene Proteins 0.000 description 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241001123635 Dipodascus Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000002038 ethyl acetate fraction Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 150000002894 organic compounds Chemical class 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- CMJHRFATHWISFN-VIFPVBQESA-N (1r)-1-cyclohexylprop-2-yn-1-ol Chemical compound C#C[C@H](O)C1CCCCC1 CMJHRFATHWISFN-VIFPVBQESA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- JDIIGWSSTNUWGK-UHFFFAOYSA-N 1h-imidazol-3-ium;chloride Chemical compound [Cl-].[NH2+]1C=CN=C1 JDIIGWSSTNUWGK-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ASNHGEVAWNWCRQ-UHFFFAOYSA-N 4-(hydroxymethyl)oxolane-2,3,4-triol Chemical compound OCC1(O)COC(O)C1O ASNHGEVAWNWCRQ-UHFFFAOYSA-N 0.000 description 1
- 108010031132 Alcohol Oxidoreductases Proteins 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241001061260 Emmelichthys struhsakeri Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000001116 FEMA 4028 Substances 0.000 description 1
- 241001123633 Galactomyces Species 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000222068 Sporobolomyces <Sporidiobolaceae> Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- ACIAHEMYLLBZOI-ZZXKWVIFSA-N Unsaturated alcohol Chemical compound CC\C(CO)=C/C ACIAHEMYLLBZOI-ZZXKWVIFSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 description 1
- 235000011175 beta-cyclodextrine Nutrition 0.000 description 1
- 229960004853 betadex Drugs 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical group [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical compound CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical class CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- VNGHLDVVHPMNAG-UHFFFAOYSA-L dipotassium butanedioate butanedioic acid Chemical compound [K+].[K+].OC(=O)CCC(O)=O.[O-]C(=O)CCC([O-])=O VNGHLDVVHPMNAG-UHFFFAOYSA-L 0.000 description 1
- SILCDLWESNHZKB-UHFFFAOYSA-L disodium 4-hydroxy-4-oxobutanoate Chemical compound [Na+].[Na+].OC(=O)CCC([O-])=O.OC(=O)CCC([O-])=O SILCDLWESNHZKB-UHFFFAOYSA-L 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- LDKQUPXYRBGLIT-UHFFFAOYSA-N non-1-yn-1-ol Chemical compound CCCCCCCC#CO LDKQUPXYRBGLIT-UHFFFAOYSA-N 0.000 description 1
- XVJKCRIRKNGKPN-UHFFFAOYSA-N non-1-yn-3-ol Chemical compound CCCCCCC(O)C#C XVJKCRIRKNGKPN-UHFFFAOYSA-N 0.000 description 1
- OQKBMYOIFQSECJ-UHFFFAOYSA-N non-1-yn-3-one Chemical compound CCCCCCC(=O)C#C OQKBMYOIFQSECJ-UHFFFAOYSA-N 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004810 partition chromatography Methods 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000036647 reaction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- IHQKEDIOMGYHEB-UHFFFAOYSA-M sodium dimethylarsinate Chemical compound [Na+].C[As](C)([O-])=O IHQKEDIOMGYHEB-UHFFFAOYSA-M 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- OESFSXYRSCBAQJ-UHFFFAOYSA-M sodium;3-carboxy-3,5-dihydroxy-5-oxopentanoate;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound [Na+].OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC([O-])=O OESFSXYRSCBAQJ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000707 stereoselective effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
Definitions
- the present invention relates to a method for producing optically active 1-six-hexyl-1-2-hydroxyl-pin-l-ol useful as a raw material for pharmaceuticals.
- prostaglandins exert a variety of important pharmacological and physiological actions in trace amounts, many derivatives have been synthesized and their biological activities have been studied.
- As one of such prostaglandin derivatives there is a prostaglandin E derivative having a triple bond at the 13-14 position of the omega chain and a terminal hexyl group at the end (Japanese Patent Application Laid-Open No. 7-2). No. 3314144).
- Such prostaglandins have many manufacturing processes, and it is necessary to supply inexpensive raw materials to develop them as pharmaceuticals.
- One of the raw materials for producing prostadalandin derivatives is 1-six-mouth hexyl 2-propynyl.
- a production method using a means of organic chemical synthesis or enzymatic synthesis has been known (US Pat. No. 4,608,388; No. 2,590,944).
- the organic chemical synthesis method has problems such as the necessity of using an expensive optical resolving agent or a catalyst and the low optical purity of the product, and the production method using an enzyme (hydrolysis of an unsaturated alcohol ester). Decomposition to obtain an optically active unsaturated alcohol) still has problems in terms of chemical yield and optical purity.
- microbial reactions may be used for organic compound synthesis.
- Examples of the synthesis of organic compounds by microbial conversion include, for example, the hydroxylation reaction of vitamin D using Nocardia and Streptomyces microorganisms, and ketone bodies using cell powder of the Candida microorganism ⁇ Geotricum genus.
- a reduction reaction for obtaining an optically active alcohol can be mentioned (Japanese Patent Application Laid-Open Nos. Hei 6-225577, JP-A-9-123498). And Japanese Unexamined Patent Publication No. 2-469.
- An object of the present invention is to provide a novel production method for producing an optically active 1-hexyl hexyl-1-propyn-1-ol. It is another object of the present invention to provide a method for producing a prostadalandin derivative using 1-cyclyl hexyl-12-propyn-1-ol produced by the method of the present invention.
- the present inventors have conducted intensive studies to achieve the above object, and as a result, have found that it is possible to produce 1-cyclohexyl-2-propyn-1-ol with high optical purity by using specific microorganisms and the like.
- the present invention has been completed.
- the method includes reducing a ketone group of 1-cyclohexyl-12-propyne-11one to a hydroxyl group using a microorganism having an activity of reducing a ketone group to a hydroxyl group, A process for producing 1-six-mouth hexyl-1-propyn-1-ol is provided.
- the method comprises reducing the cells of a microorganism having the activity of reducing a ketone group to a hydroxyl group or a processed product thereof, a culture solution of the microorganism, or a ketone group produced by the microorganism to a hydroxyl group.
- the method includes contacting an enzyme having activity with 1-cyclohexyl-2-propyn-1-one to effect a reduction reaction of a ketone group.
- the microorganism is a filamentous fungus. More preferably, the microorganism is at least one microorganism selected from the group consisting of the genus Geotrichum, the genus Endomyces, the genus Galactomyces, and the genus Dipodascus. Particularly preferably, the microorganism is Geotrichum candidum, Geotrichum armillariae, or Galacttomyces geotrichum. , Galacttomyces reessii, and one or more microorganisms selected from the group consisting of Endomyces geotrichum.
- the ketone group of 1-cyclohexyl-12-propyne-11one is stereoselectively reduced to a hydroxyl group to obtain an optically active 1-hexylhexyl-2-propyne-1-one. Produce one oar.
- 1-cyclohexyl-2-propyn-1-ol is produced by the above-described method of the present invention, and then the produced 1-cyclohexyl-1-propyn-1-ol is produced.
- a method for producing a prostaglandin derivative comprising producing a prostaglandin derivative using the method.
- 1-cyclohexyl-1-propyn-1-ol is produced by reducing the ketone group of 1-hexoxyl-2-propyne-11one to a hydroxyl group.
- FIG. 1 shows the 1 H-NMR (CDC13, 500 MHz) of each optically active cyclohexyl-2-propyn-1-ol obtained by the reaction using the IFO 4597 strain.
- FIG. 2 shows the 13 C-NMR (CDC13, 125 MHz) of each optically active cyclohexyl-2-propyn-1-ol obtained by the reaction using the IF04597 strain.
- the method for producing 1-cyclohexyl-2-propyn-1-ol comprises the steps of producing 1-cyclohexyl-1-propyn-1-one by using a microorganism having an activity of reducing a ketone group to a hydroxyl group. It is characterized in that a ketone group is reduced to a hydroxyl group.
- the microorganism used in the present invention is not particularly limited as long as it has a desired reducing activity, but is preferably a filamentous fungus, and more preferably Geotrichum. ) Genus, genus Endomyces, genus Galacttomyces or genus Dipodascus.
- JCM Microorganism Strain Conservation Facility
- IFO Fermentation Research Institute
- a microorganism into which a gene for a reductase possessed by these microorganisms has been introduced and which can stereoselectively reduce the ketone group of 1-cyclyl hexyl-2-propyn-1-one to a hydroxyl group can also be used.
- a carbonyl reductase gene derived from a yeast belonging to the genus Sporobolomyces Japanese Patent Laid-Open No. 08-103269
- a carbyl reductase gene derived from a yeast belonging to the genus Candida US Pat. No. 6,218, No. 1536
- the cells or spores of the microorganism are mutated by, for example, UV irradiation treatment or NTG (N-methyl-N'-nitro-N-nitrosoguanidine, l-metnyl-3-nitro-l-nitrosoguanidine) treatment, etc. More preferable microorganisms can be obtained and obtained.
- the strain is cultured in a medium under aerobic conditions.
- the medium used is mainly a liquid medium, and as a carbon source, darcos, manoletose, dextroses, starch, stomach / meat, arabinose, xylose, and sucrose are used alone or in combination.
- peptone, casein, polypeptone, soy peptone, yeast extract, meat extract, corn steep liquor, malt extract, cottonseed meal, gluten meal and soy flour are used alone or in combination.
- a commercially available mixed medium eg, Eiken GP medium, etc.
- organic and inorganic substances that promote the growth of this strain and promote the production of optically active 1-cyclohexyl-2-propyn-1-ol can be added as necessary.
- a culture method it is preferable to culture at pH 5 to 8 and 22 to 30 for 1 to 5 days under aerobic conditions such as shaking culture and aeration and stirring culture.
- the use of a cell of a microorganism obtained by the above-described culture or a processed product thereof, a culture solution of the microorganism, or an enzyme having an activity of reducing a ketone group produced by the microorganism to a hydroxyl group A reaction is performed to produce the (S) -form or (R) -form of 1-cyclohexyl 2-propyn-1-ol, ie, optically active 1-cyclohexyl-2-propyn-1-ol.
- the cells used for the reaction may be used as they are, or processed cells, for example, crushed cells, freeze-dried, etc. may be used.
- a culture solution of the microorganism can be used, and an enzyme having an activity of reducing a ketone group produced by the microorganism to a hydroxyl group can also be used.
- the enzyme can be obtained by purifying the enzyme by appropriately combining conventional methods.
- the above-mentioned microbial cells and the enzymes produced by the cells include photocrosslinkable resin prepolymers, such as ENT340 (trade name; manufactured by Kansai Paint Co., Ltd.) and urethane prepolymers, such as PU-9 (Trade name; manufactured by Toyo Tire & Rubber Co., Ltd.) or K- Ichi Laginan or other polysaccharides before use in the reaction.
- ENT340 trade name; manufactured by Kansai Paint Co., Ltd.
- urethane prepolymers such as PU-9 (Trade name; manufactured by Toyo Tire & Rubber Co., Ltd.) or K- Ichi Laginan or other polysaccharides before use in the reaction.
- a substrate in addition to using the cells of the microorganisms obtained by the culture, for example, a substrate may be added to a culture solution containing the cells in the culture, or after completion of the culture, centrifugation or The cells isolated by filtration may be crushed to extract the enzyme produced, and a substrate may be added thereto for reaction.
- Organic substances such as cyclodextrins such as ⁇ -cyclodextrin, ⁇ -cyclodextrin, and -cyclodextrin, adsorbents such as Amperlite XAD-7 (trade name, manufactured by Organo Corporation), and the like, Alternatively, a surfactant such as Tween 80 or magnesium chloride Inorganic salts such as platinum can be added for the purpose of accelerating the reaction.
- the reaction solution used in the present invention may be a force that is a culture solution cultured using the above-described medium, or trisacetic acid, tris-hydrochloric acid, sodium succinate-succinic acid, potassium succinate-succinic acid, sodium citrate-monocitrate , Potassium and phosphate such as sodium trim, and buffers such as sodium cacodylate monohydrochloride, imidazole-hydrochloric acid, and boric acid monoborane.
- an organic substance, a surfactant, and an inorganic salt which promote the production of the desired optically active 1-hexyl-2-propyn-1-ol can be added to the solution, if necessary.
- the present invention it is suitable to carry out shaking operation, aeration stirring culture operation and the like in a solution containing the cells under aerobic conditions, pH 5 to 9, 18 to 3 It is preferable to shake and stir at 7 for 1 to 10 days. If necessary, the reaction can be carried out under a stream of oxygen or a stream of an inert gas such as argon or nitrogen. It is preferable to add an appropriate amount of the substrate at the start of shaking and stirring.
- the reaction is performed under the same conditions as above after adding the substrate.
- the optically active 1-cyclohexyl-2-propyn-1-ol produced by these reactions can be isolated according to a general method for isolating a secondary alcohol from a synthesis reaction solution. For example, after completion of the reaction, the reaction solution is extracted with an organic solvent such as ethyl acetate. After separating and concentrating the organic solvent layer, a normal-phase silica gel column (Kieselgel 60 F254 or Rover Column Si 60, manufactured by Merck) or a reverse-phase silica gel column (Roper column, Licroblep C18, The desired optically active 1-cyclohexyl-1-propyn-1-ol can be isolated by purifying the product using Merck Co., Ltd.).
- Optical activity is also obtained by partition chromatography using SEPHADEX LH-20 (manufactured by Pharmacia), thin-layer chromatography of silica gel, and Diaion HP-20 (trade name; manufactured by Mitsubishi Kasei Kogyo).
- 1-cyclohexyl-2-propyn-1-ol can be isolated.
- a ketone group is produced in order to produce 1-six-hexyl-1-propyn-1-ol by reducing the ketone group of 1-six-hexyl 2-propyne-one to a hydroxyl group.
- a microorganism having an activity of reducing to a hydroxyl group can be used. The use of the microorganisms described above, regardless of its mode, is all within the scope of the present invention.
- a prostaglandin derivative can be produced using 1-cyclohexyl-12-propyn-11-ol produced by the above method.
- Methods for producing prostaglandin derivatives using 1-six-mouth hexinole-1-propionate are known, for example, F. Sato, J. Org.Chem., 1991, 56, 3205-3207, and It is described in, for example, Japanese Patent No. 29175752.
- Each of the strains to be tested was inoculated into a 5 ml GP medium (manufactured by Eiken Chemical) placed in a 50 ml Erlenmeyer flask, and cultured with aeration and agitation at 30 ° C for 17 hours. After the cultivation, 2 O mg of 1-hexyl-2-propyn-1-one was added to each Erlenmeyer flask, followed by culturing under the same conditions for 24 hours, followed by microbial conversion.
- a 5 ml GP medium manufactured by Eiken Chemical
- strains shown in Table 3 were inoculated into a 40 ml GP medium (Eiken Chemical) placed in a 200 ml Erlenmeyer flask for 17 hours.
- the culture was carried out at 0 ° C with aeration and stirring. After the culture, the culture was centrifuged to collect the cells, and each cell was suspended in a sodium phosphate buffer (100 mM, pH 7.5) at 40 ml and separately placed in a 200 ml Erlenmeyer flask.
- a sodium phosphate buffer 100 mM, pH 7.5
- FIGS. 1 and 2 show the results of NMR of the compound obtained using the IF04597 strain. NMR of each isolated optically active cyclohexyl-2-propyne-1-ol was obtained by chemical synthesis. (1) NMR of (1S) -cyclohexyl-1-propyn-1-ol. And perfectly matched. Industrial applicability
- the 1-position of 1-cyclohexyl-1-propyne-1-one By directly reducing the carbon atom of the ponyl group in a stereoselective manner, it has become possible to produce 1-cyclohexyl-2-propyn-1-ol with high optical purity.
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004555042A JPWO2004048586A1 (ja) | 2002-11-27 | 2003-11-26 | 光学活性な1−シクロヘキシル−2−プロピン−1−オールの製造方法 |
AU2003284450A AU2003284450A1 (en) | 2002-11-27 | 2003-11-26 | Process for producing optically active 1-cyclohexyl-2-propyn-1-ol |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-344707 | 2002-11-27 | ||
JP2002344707 | 2002-11-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004048586A1 true WO2004048586A1 (ja) | 2004-06-10 |
Family
ID=32375964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/015071 WO2004048586A1 (ja) | 2002-11-27 | 2003-11-26 | 光学活性な1−シクロヘキシル−2−プロピン−1−オールの製造方法 |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2004048586A1 (ja) |
AU (1) | AU2003284450A1 (ja) |
WO (1) | WO2004048586A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005245444A (ja) * | 2004-02-06 | 2005-09-15 | Daiichi Fine Chemical Co Ltd | 1−シクロアルキル−2−プロピン−1−オールの光学活性体の製造方法 |
CN107418981A (zh) * | 2017-06-27 | 2017-12-01 | 中山大学 | 白地霉菌株不对称催化还原卤代芳香酮的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989010410A1 (en) * | 1988-04-27 | 1989-11-02 | Daicel Chemical Industries, Ltd. | Process for preparing optically active 1,3-butanediol |
WO2001005996A1 (fr) * | 1999-07-21 | 2001-01-25 | Kaneka Corporation | Procede d'obtention de derives optiquement actifs du pyridineethanol |
-
2003
- 2003-11-26 JP JP2004555042A patent/JPWO2004048586A1/ja active Pending
- 2003-11-26 AU AU2003284450A patent/AU2003284450A1/en not_active Abandoned
- 2003-11-26 WO PCT/JP2003/015071 patent/WO2004048586A1/ja active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1989010410A1 (en) * | 1988-04-27 | 1989-11-02 | Daicel Chemical Industries, Ltd. | Process for preparing optically active 1,3-butanediol |
WO2001005996A1 (fr) * | 1999-07-21 | 2001-01-25 | Kaneka Corporation | Procede d'obtention de derives optiquement actifs du pyridineethanol |
Non-Patent Citations (2)
Title |
---|
KAORU NAKAMURA ET AL.: "Asymmetric synthesis of both enantiomers of secondary alcohols by reduction with a single microbe", TETRAHEDRON LETTERS, vol. 43, no. 20, May 2002 (2002-05-01), pages 3629 - 3631, XP004350579 * |
SILHANKOVA L. ET AL.: "Production of NADH by microbial reduction of added NAD+", BIOTECHNOLOGY TECHNIQUES, vol. 6, no. 5, 1992, pages 455 - 460, XP002976201 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005245444A (ja) * | 2004-02-06 | 2005-09-15 | Daiichi Fine Chemical Co Ltd | 1−シクロアルキル−2−プロピン−1−オールの光学活性体の製造方法 |
JP4580772B2 (ja) * | 2004-02-06 | 2010-11-17 | 第一ファインケミカル株式会社 | 1−シクロアルキル−2−プロピン−1−オールの光学活性体の製造方法 |
CN107418981A (zh) * | 2017-06-27 | 2017-12-01 | 中山大学 | 白地霉菌株不对称催化还原卤代芳香酮的方法 |
Also Published As
Publication number | Publication date |
---|---|
AU2003284450A1 (en) | 2004-06-18 |
JPWO2004048586A1 (ja) | 2006-03-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Patel et al. | Enantioselective microbial reduction of 3, 5-dioxo-6-(benzyloxy) hexanoic acid, ethyl ester | |
JPH06209782A (ja) | 光学活性4−ハロ−3−ヒドロキシ酪酸エステルの製造方法 | |
JP5090910B2 (ja) | 光学活性2−(n−置換アミノメチル)−3−ヒドロキシ酪酸エステル類の製造方法 | |
EP2857496B1 (en) | D-glucaric acid-producing bacterium, and method for manufacturing d-glucaric acid | |
JP4394647B2 (ja) | 光学活性テトラヒドロチオフェン誘導体の製造方法、および、光学活性テトラヒドロチオフェン−3−オールの晶析方法 | |
JP3201411B2 (ja) | ビタミンd類の生物学的製造方法 | |
WO2004048586A1 (ja) | 光学活性な1−シクロヘキシル−2−プロピン−1−オールの製造方法 | |
EP0425001B1 (en) | Natural delta-lactones and process of the production thereof | |
JP2010532992A (ja) | 3,4−エポキシ酪酸エチルの微生物速度論的分割 | |
JP2663294B2 (ja) | ビタミンd類の製造方法 | |
JPH07241197A (ja) | 25−ヒドロキシビタミンd類の製造法 | |
JP4449015B2 (ja) | シクロスポリン誘導体の製造方法 | |
JP4399234B2 (ja) | 有用変換微生物 | |
AU773234B2 (en) | A process for the preparation of derivatives of Ruscus aculeatus steroid glycosides | |
JPH08149986A (ja) | 12−ヒドロキシ−6−o−アルキルエリスロマイシン及びその類縁体の製造方法 | |
JP4439079B2 (ja) | プラバスタチンの製造方法 | |
WO2000037666A1 (fr) | Procede de production de derive (r)-2-hydroxy-1-phenoxypropane | |
JP3957053B2 (ja) | 新規な微生物及びプラバスタチンの製造方法 | |
JP5474280B2 (ja) | 光学活性なtrans体含窒素環状β−ヒドロキシエステルの製造方法 | |
JP2006314248A (ja) | トリテルペン誘導体の製造方法 | |
JPS60995B2 (ja) | 7−アミノ−セフアロスポラン酸およびその誘導体の新規製造法 | |
JP2005278525A (ja) | 芳香族化合物の製造方法 | |
JPH0889277A (ja) | 12−ヒドロキシ−6−o−アルキルエリスロマイシン及びその類縁体の製造方法 | |
WO1996010029A1 (fr) | Procede de production de 12-hydroxy-6-o-alkylerythromycine et d'analogues de cette substance | |
JPH0464678B2 (ja) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004555042 Country of ref document: JP |
|
122 | Ep: pct application non-entry in european phase |